Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system

Clinical Chemistry

Volumn 45, Issue 11, 1999, Pages 1918-1924

  Raggi, Claudia Casini ^a   Bagnoni, Maria Letizia ^a   Tonini, Gian Paolo ^a   Maggi, Mario ^b   Vona, Giovanna ^a   Pinzani, Pamela ^a   Mazzocco, Katia ^a   De Bernardi, Bruno ^c   Pazzagli, Mario ^a   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Advanced Biotechnology Centre   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAQ POLYMERASE;

ACCURACY; ARTICLE; CANCER SURVIVAL; GENE AMPLIFICATION; HUMAN; MEASUREMENT; NEUROBLASTOMA; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PREDICTION; QUANTITATIVE GENETICS; REPRODUCIBILITY;

EID: 0032759838     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.11.1918     Document Type: Article

References (40)

1. 1. Young JL, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival and mortality for children under 15 years of age. Cancer 1986;58:598-602.
2. 2. Castleberry RP. Neuroblastoma. Eur J Cancer 1997;33. 1430-8.
3. 3. Evans AE, D'Angio GJ, Randolph JA. A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 1971;27:374-8.
4. 4. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatrics oncology. Philadelphia, PA: JB Lippincott, 1997:761-97.
5. 5. Tonini GP, Boni L, Pession A, Rogers D, Iolascon A, Basso G, et al. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol 1997;15:85-93.
6. 6. Hahn HWL, Levy HM, Evans AE. Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res 1980;40:1411-3.
7. 7. Zeltzer PM, Marangos PJ, Evans AE, Schneider SL. Serum neuron specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 1986;57:1230-4.
8. 8. Shuster JJ, McWilliams NB, Castleberry R, Nitschke R, Smith El, Altshuler G, et al. Serum lactate dehydrogenase in childhood neuroblastoma. Am J Clin Oncol 1992;15:295-303.
9. 9. Bertani-Dziedzic L, Dziedzic SW, Gitlow SE. Catecholamine metabolism in neuroblastoma. In: Pochedly C, ed. Neuroblastoma: tumor biology and therapy. Boca Raton, FL: CRC Press, 1990:69-91.
10. 10. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995;24:215-21.
11. 11. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Brodeur GM. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. New Engl J Med 1984;311:231-5.
12. 12. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high risk levels of expression of the TRK expression in non-advanced stages. Int J Cancer 1993;328:847-54.
13. 13. Chan HSL, Haddad G, Thorner PS. P-Glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. New Engl J Med 1991;325:1608-14.
14. 14. Norris MD, Bordow SB, Marshall GM, Haber PS, Haber M. Association between high levels of expression of the multidrug resistance-associated protein (MRP) gene and poor outcome in primary human neuroblastoma. New Engl J Med 1996;334: 231-8.
15. 15. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, et al. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993;8:855-65.
16. 16. Favrot MC, Combaret V, Lasset C. CD44 - a new prognostic marker for neuroblastoma. New Engl J Med 1993;329:1965.
17. 17. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek M, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
18. 18. Sestini R, Orlando C, Peri A, Tricarico C, Pazzagli M, Serio M, et al. Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell line and primary tumors using competitive reverse transcription-polymerase chain reaction. Clin Cancer Res 1996;2:1757-65.
19. 19. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
20. 20. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple copies of MYCN oncogene with rapid progression of neuroblastoma. N Engl J Med 1985;313: 1111-6.
21. 21. Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, et al. Analysis of MYCN amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer 1987;60: 820-6.
22. 22. Taylor SR, Lochker J. A comparative analysis of nuclear content and MYCN amplification in neuroblastoma. Cancer 1990;65: 1360-6.
23. 23. Bourhis J, De Vathaire F, Wilson GD, Hartmann O, Terrier-Lacomb MJ, Boccon-Gibod L, et al. Combined analysis of DNA ploidy index and MYCN genomic content in neuroblastoma. Cancer Res 1991; 51:33-6.
24. 24. Sansone R, Strigini P, Badiali M, Dominici C, Fontana V, Iolascon A, et al. Age-dependent prognostic significance of MYCN amplification in neuroblastoma. Cancer Genet Cytogenet 1991;54: 253-7.
25. 25. Muraji T, Okamoto E, Fujimoto J, Suita S, Nakagawara A. Combined determination of MYCN oncogene amplification and DNA ploidy in neuroblastoma. Cancer 1993;72:2763-8.
26. 26. Christiansen H, Sahin K, Berthold F, Hero B, Terpe H-J, Lampert F. Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma. Eur J Cancer 1995;31A:541-4.
27. 27. Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, et al. Localized neuroblastoma: MYCN amplification is the main prognostic factor-results of the NBL 90 study. J Clin Oncol 1997;15:1171-82.
28. 28. Alitalo K, Schwab M. Oncogene amplification in tumor cells. Adv Cancer Res 1986;47:235-81.
29. 29. Pession A, Trere D, Perri P, Rondelli R, Montanaro L, Montanari W, et al. MYCN amplification and cell proliferation rate in human neuroblastoma. J Pathol 1997;183:339-44.
30. 30. de Cremoux P, Thioux M, Peter M, Vielh P, Michon JJ, Delattre O, Magdelenat H. Polymerase chain reaction compared with dot blotting for the determination of MYCN gone amplification in neuroblastoma. Int J Cancer 1997;72:518-21.
31. 31. Sestini R, Orlando C, Zentilin L, Gelmini S, Pinzani P, Bianchi S. et al. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin Chem 1994;40:630-6.
32. 32. Sestini R, Orlando C, Zentilin L, Lami D, Gelmini S, Pinzani P, et al. Gene amplification for c-erbB-2, c-myc, EGF receptor, int-2 and N-myc measured by quantitative PCR with a multiple competitor template. Clin Chem 1995;41:826-32.
33. 33. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, Look AT. Detection of MYCN gene amplification by fluorescent in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol 1993;142:1339-46.
34. 34. Gelmini S, Orlando C, Sestini R, Vona G, Pinzani P, Ruocco L, Pazzagli M. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. Clin Chem 1997;43:752-8.
35. 35. Orlando C, Pinzani P, Pazzagli M. Developments in quantitative PCR. Clin Chem Lab Med 1998;36:255-69.
36. 36. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989:16-9.
37. 37. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castelberry RP, De Bernardi B, et al. Revisions in the international criteria for neuroblastoma diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1993;11:1466-77.
38. 38. Kaplan E, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;58:457-81.
39. 39. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276-80.
40. 40. Gibson U, Heid C, Williams M. A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.